Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
DNA Repair|June 9, 2012
The prostate cancer risk locus at 10q11 is associated with DNA repair capacityAntje E Rinckleb, Harald M Surowy, Manuel Luedeke, et al.Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|December 4, 2012
[Integrating the e-learning programme EGONE into the block of training in obstetrics and gynaecology]Laura Weninger, Hubert Liebhardt, Stephanie Brachmann, et al.Mutagenesis|September 25, 2004
An automated scoring procedure for the micronucleus test by image analysisDominic Varga, Tilman Johannes, Silke Jainta, et al.Mutagenesis|April 8, 2006
Scoring variability of micronuclei in binucleated human lymphocytes in a case-control studyBrenda Patino-Garcia, Josef Hoegel, Dominic Varga, et al.Archives of Gynecology and Obstetrics|January 5, 2010
Comparison of early onset breast cancer patients to older premenopausal breast cancer patientsDominic Varga, Jochem Koenig, Kathrin Kuhr, et al.Gynecologic Oncology|August 13, 2013
The role of preoperative ultrasound evaluation of inguinal lymph nodes in patients with vulvar malignancyNikolaus de Gregorio, Florian Ebner, Lukas Schwentner, et al.Mutagenesis|August 25, 2006
On the difference of micronucleus frequencies in peripheral blood lymphocytes between breast cancer patients and controlsDominic Varga, Josef Hoegel, Christiane Maier, et al.International Journal of Cancer|October 19, 2017
A low-frequency haplotype spanning SLX4/FANCP constitutes a new risk locus for early-onset breast cancer (<60 years) and is associated with reduced DNA repair capacityHarald Surowy, Dominic Varga, Barbara Burwinkel, et al.International Journal of Cancer|April 5, 2014
Validation of the Manchester scoring system for predicting BRCA1/2 mutations in 9,390 families suspected of having hereditary breast and ovarian cancerKarin Kast, Rita K Schmutzler, Kerstin Rhiem, et al.Breast Cancer Research : BCR|December 11, 2012
The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort studyKerstin Rhiem, Christoph Engel, Monika Graeser, et al.Pageof 3